Cite

HARVARD Citation

    Astegiano, M. et al. (n.d.). OC.14.7: The Role of Anti-IFI16 Antibodies in the Management of Inflammatory Bowel Diseases (IBD). Digestive and liver disease. pp. e119-. [Online]. 
  
Back to record